Comparison of vortioxetine and sertraline for treatment of major depressive disorder in elderly patients: A double‐blind randomized trial.

What is known and objective: Major depressive disorder (MDD) is a complex disease and one of the leading contributors to disease burden throughout the world. In the current study, we explored the efficacy and tolerability of vortioxetine versus sertraline on symptoms of depression in elderly patient...

Descripción completa

Detalles Bibliográficos
Publicado en:Journal of Clinical Pharmacy & Therapeutics Vol. 45; no. 4; pp. 804 - 812
Autores principales: Borhannejad, Firouzeh, Shariati, Behnam, Naderi, Sina, Shalbafan, Mohammadreza, Mortezaei, Amirhosein, Sahebolzamani, Erfan, Saeb, Atefe, Hosein Mortazavi, Seyyed, Kamalzadeh, Leila, Aqamolaei, Ali, Ali Noorbala, Ahmad, Namazi‐Shabestari, Alireza, Akhondzadeh, Shahin
Formato: research tables/charts randomized controlled trial Journal Article
Publicado: Wiley-Blackwell Aug2020
Acceso en línea:Ver este registro en EBSCOhost
fields @attributes:
  recordID: 1
pdfLink:
plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=144405618&site=ehost-live
header:
  @attributes:
    shortDbName: ccm
    uiTerm: 144405618
    longDbName: CINAHL Complete
    uiTag: AN
  controlInfo:
    bkinfo:
    dissinfo:
    jinfo:
      jid:
        02694727
        EV4
      jtl: Journal of Clinical Pharmacy & Therapeutics
      issn: 02694727
      maglogo: Y
    pubinfo:
      dt: Aug2020
      vid: 45
      iid: 4
      pid: 480
      pub: Wiley-Blackwell
      place: Malden, Massachusetts
    artinfo:
      ui:
        144405618
        144405618
        144405618
        10.1111/jcpt.13177
        144405618
      ppf: 804
      ppct: 8
      formats:
        fmt:
          – @attributes:
              type: T
          – @attributes:
              type: C
          – @attributes:
              type: P
      tig:
        atl: Comparison of vortioxetine and sertraline for treatment of major depressive disorder in elderly patients: A double‐blind randomized trial.
      aug:
        au:
          Borhannejad, Firouzeh
          Shariati, Behnam
          Naderi, Sina
          Shalbafan, Mohammadreza
          Mortezaei, Amirhosein
          Sahebolzamani, Erfan
          Saeb, Atefe
          Hosein Mortazavi, Seyyed
          Kamalzadeh, Leila
          Aqamolaei, Ali
          Ali Noorbala, Ahmad
          Namazi‐Shabestari, Alireza
          Akhondzadeh, Shahin
        affil: Psychiatric Research Center, Roozbeh Psychiatric Hospital, Tehran University of Medical Sciences, Tehran, Iran
      sug:
        subj:
          Depression Drug Therapy
          Depression Symptoms
          Piperidines Therapeutic Use
          Sertraline Hydrochloride Therapeutic Use
          Antidepressive Agents Therapeutic Use
          Treatment Outcomes
          Human
          Randomized Controlled Trials
          Random Assignment
          Double-Blind Studies
          Piperidines Administration and Dosage
          Sertraline Hydrochloride Administration and Dosage
          Comparative Studies
          Repeated Measures
          Patient Safety
          Hamilton Rating Scale for Depression
          Psychological Tests
          Aged
          Aged: 65+ years
      ab: What is known and objective: Major depressive disorder (MDD) is a complex disease and one of the leading contributors to disease burden throughout the world. In the current study, we explored the efficacy and tolerability of vortioxetine versus sertraline on symptoms of depression in elderly patients with MDD. Methods: Sixty patients diagnosed with MDD (based on DSM‐5) and Hamilton Depression Rating Scale (HAM‐D) score ≥ 19 were entered into a randomized double‐blind study and were randomized to receive either vortioxetine (15 mg daily) or sertraline (75 mg daily) for six weeks. Patients were assessed using the HAM‐D scale at baseline and weeks 3 and 6. Changes in HAM‐D score, response rates, remission rate and time to response or remission were also compared between the two study groups. Results and Discussion: Fifty patients completed the trial after six weeks. General linear model repeated measures demonstrated no difference in trend of the two treatment groups (P =.897). There was no significantly different improvement in the HDRS scores from baseline to weeks 3 and 6, as well. Differences in response rate, remission rate, time to response and time to remission periods were not statistically significant. Finally, there was not any significantly difference between the two study groups in the frequency of adverse events. What is new and conclusion: This study showed no significant differences in the efficacy and safety of vortioxetine in comparison with sertraline in order for it to be used safely for treatment of major depressive disorder in elderly patients.
      pubtype: Academic Journal
      doctype:
        research
        tables/charts
        randomized controlled trial
        Journal Article
      ougenre: Article
    language: English
    refInfo:
    holdings:
      @attributes:
        islocal: N